Peter MacCallum Cancer Centre Standardizes on Varian Solution for Cancer Treatment Planning | Varian

Peter MacCallum Cancer Centre Standardizes on Varian Solution for Cancer Treatment Planning

PALO ALTO, Calif., Dec. 12, 2017 /PRNewswire/ -- Varian (NYSE: VAR) today announced the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia has selected the Eclipse treatment planning system to replace its existing cancer treatment planning systems across all five Peter Mac sites. As the first Microsoft Azure-hosted system to be deployed in Australia, the Varian solution includes Eclipse as well as Velocity for adaptive radiotherapy.

"Peter Mac has been using three different treatment planning systems across our five sites, which has increased the level of resources required to maintain and commission multiple systems," said Peter Mac's director of Radiation Oncology, Professor Trevor Leong. "This also poses a challenge for staff as they move around our different centres and are required to learn different systems. Standardizing on the Eclipse treatment planning system will translate to increased efficiency, increased staff satisfaction and more time to concentrate on patient care."

Chris Cowley, managing director for Varian in Australia, said: "We are proud of our ongoing partnership with Peter Mac and its selection of the Varian solution to provide the most advanced adaptive treatment planning available from anywhere and at any time across the network of their sites. We look forward to collaborating with Peter Mac on the deployment of this solution and together helping create a world without the fear of cancer."

Eclipse software creates an optimized radiotherapy treatment plan based on a physician's dose instructions, and information about the size, shape, and location of the tumor to be treated with radiation. The Eclipse software incorporates unique features such as RapidPlan™ knowledge-based planning, and multi-criteria optimization (MCO). RapidPlan is designed to simplify and accelerate the planning process for sophisticated cancer treatments like stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), intensity-modulated radiotherapy (IMRT), and RapidArc® radiotherapy. MCO allows clinicians to explore what happens when different clinical criteria are varied, such as the degree to which particular organs are spared versus coverage of the targeted tumor. 

The Velocity system offers large-scale archival image storage and management and serves as a centralized repository for all diagnostic, planning and delivery information. 

Varian booked the Peter Mac order in the fourth quarter of its fiscal year 2017.

About Varian
Varian focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit and follow @VarianMedSys on Twitter.

About Peter Mac
Peter MacCallum Cancer Centre is one of the world's leading cancer research, education and treatment centres globally and is Australia's only public hospital solely dedicated to caring for people affected by cancer. We have over 2,500 staff, including more than 580 laboratory and clinical researchers, all focused on providing better treatments, better care and potential cures for cancer.

Press Contact

Mark Plungy
+1 (650) 424-5630